CSL - Cash And Equivalent

Stock Price
128.90
Daily Change
-2.92 -2.22%
Monthly
-8.46%
Yearly
-47.48%
Q2 Forecast
127.56

CSL reported $2.16B in Cash and Equivalent for its fiscal semester ending in June of 2025.





Cash And Equivalent Change Date
Alterity Therapeutics Limited AUD 15.77M 9.56M Jun/2023
Arca Biopharma USD 46.93M 44.32M Dec/2025
aTyr Pharma USD 6.15M 11.07M Sep/2025
Bio Path 13.65M 3.37M Sep/2022
Brainstorm Cell Therapeutics USD 5K 819K Sep/2025
Cara Therapeutics USD 21.42M 770K Sep/2025
CSL USD 2.16B 633M Jun/2025
Curis USD 10.14M 10.14M Jun/2025
Esperion Therapeutics USD 92.45M 6.39M Sep/2025
Immunic USD 15.48M 19.65M Dec/2025
Infinity Pharmaceuticals USD 17.75M 7.99M Jun/2023
Minerva Neurosciences USD 82.3M 70.02M Dec/2025
Sangamo BioSciences USD 38.34M 13.16M Jun/2025
TherapeuticsMD 523K 89K Jun/2024